心脏病综合征:一篇文学评论
Abimbola O Ajibowo1, Okelue E Okobi2,3, Erhieyovbe Emore4
1Internal Medicine, Lugansk Medical University, Lugansk, UKR.
Cureus
|August 2, 2023
概括
心脏病综合征 (CRS) 涉及到心脏和脏功能障碍. 生物标志物是早期诊断,预后和管理这种复杂疾病的关键.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物标志物研究 生物标志物研究
背景情况:
- 心脏病综合征 (CRS) 描述了心脏和功能障碍之间的双向关系.
- 血液动力学和非血液动力学因素极大地影响了CRS的发展和进展.
- 了解CRS是至关重要的,因为它对急性和慢性器官损伤的影响.
研究的目的:
- 审查生物标志物在诊断心脏病综合征中的临床意义.
- 探索生物标志物在预测CRS患者预后方面的作用.
- 讨论生物标志物在治疗心脏病综合征中的应用.
主要方法:
- 综合性文献综述,重点关注心脏病综合征.
- 对研究CRS中血液动力学和非血液动力学因素的分析.
- 在临床环境中对CRS生物标志物实用性的评估.
主要成果:
- 生物标志物有助于早期发现心脏病综合征.
- 特定的生物标志物与CRS的预后和疾病严重程度相关.
- 神经激素和炎症标记在CRS病理生理学中具有重要意义.
结论:
- 生物标志物是诊断,预后和治疗心脏病综合征的重要工具.
- 需要进一步的研究来推进CRS的临床管理.
- 通过生物标志物的早期识别可导致及时干预.
相关概念视频
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...


